Rebirth PCT
Rebirth PCT by Huge Supplements is an 'Other Combinations' type product with 11 ingredients, categorized under Omega & Fish Oil. It achieves an N+ Score of 58, earning an 'F' grade, indicating a below-average quality assessment. The product includes a clinical dose of Zinc at 25mg, alongside 2000mg of D-Aspartic Acid and 500mg of Ashwagandha. However, both Vitamin D3 and Magnesium are present in underdosed amounts. This supplement is intended for individuals seeking a multi-ingredient approach, potentially for post-cycle support, but should note the underdosed key vitamins and minerals.
About This Product
Rebirth PCT by Huge Supplements is a omega & fish oil supplement containing 11 active ingredients. It has earned an N+ Score of 58/100 (Grade F).
Notable clinical-dose ingredients include Zinc.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +1 ingredient(s) at clinical dose levels
- +Rich formula with 11 active ingredients
Weaknesses
- −Several ingredients below clinically effective doses
- −Missing several expected ingredients for its category
Ingredient Analysis (11 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Magnesium | 45.000 mg | Under |
| Zinc | 25.000 mg | Optimal |
| Boron | 5.000 mg | N/A |
| Vitamin D3 | 50.000 mcg | Under |
| D-Aspartic Acid | 2000.000 mg | N/A |
| Black Pepper (fruit) extract | 5.000 mg | N/A |
| Tribulus terrestris | 500.000 mg | N/A |
| Ashwagandha | 500.000 mg | N/A |
| Safed Musli | 500.000 mg | N/A |
| Diindoly methane | 200.000 mg | N/A |
| Acacetin | 75.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.
